Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);喜树碱(Camptothecin);细胞系, 肿瘤(Cell Line, Tumor);细胞周期蛋白D1(Cyclin D1);药物疗法, 联合(Drug Therapy, Combination);内皮, 血管(Endothelium, Vascular);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);基因表达调控(Gene Expression Regulation);人类(Humans);磷酰化(Phosphorylation);蛋白激酶抑制剂(Protein Kinase Inhibitors);吡唑类(Pyrazoles);嘧啶类(Pyrimidines)
DOI
10.1016/j.bcp.2011.03.022
PMID
21459081
发布时间
2018-12-01
- 浏览94

Biochemical pharmacology
1309-16页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文